2014Antiviral Research110 : 52-9
Development of a high-throughput pyrosequencing assay for monitoring temporal evolution and resistance associated variant emergence in the Hepatitis C virus protease coding-region
Irving W, Rupp D, McClure C, Than L, Titman A, Ball J, Steinmann E, Bartenschlager R, Pietschmann T, Brown R
2014Journal of Virology88 (21) : 12644-55
Role of hypervariable region 1 for the interplay of hepatitis C virus with entry factors and lipoproteins
Bankwitz D, Vieyres G, Hueging K, Bitzegeio J, Doepke M, Chhatwal P, Haid S, Catanese M, Zeisel M, Nicosia A, Baumert T, Kaderali L, Pietschmann T
2015Hepatology (baltimore, Md.)61 (2) : 447-59
Clinical course of infection and viral tissue tropism of hepatitis C virus-like nonprimate hepaciviruses in horses
Pfaender S, Cavalleri J, Walter S, Doerrbecker J, Campana B, Brown R, Burbelo P, Postel A, Hahn K, Anggakusuma, Riebesehl N, Baumgärtner W, Becher P, Heim M, Pietschmann T, Feige K, Steinmann E
2015Applied and Environmental Microbiology81 (5) : 1616-21
Mechanisms of methods for hepatitis C virus inactivation
Pfaender S, Brinkmann J, Todt D, Riebesehl N, Steinmann J, Steinmann J, Pietschmann T, Steinmann E
2014Hepatology (baltimore, Md.)59 (1) : 78-88
Cell entry, efficient RNA replication, and production of infectious hepatitis C virus progeny in mouse liver-derived cells
Frentzen A, Anggakusuma, Gürlevik E, Hueging K, Knocke S, Ginkel C, Brown R, Heim M, Dill M, Kröger A, Kalinke U, Kaderali L, Kuehnel F, Pietschmann T
2015Journal of Virology89 (7) : 3833-45
Control of hepatitis C virus replication in mouse liver-derived cells by MAVS-dependent production of type I and type III interferons
Anggakusuma, Frentzen A, Gürlevik E, Yuan Q, Steinmann E, Ott M, Staeheli P, Schmid-Burgk J, Schmidt T, Hornung V, Kuehnel F, Pietschmann T
2015Hepatology (baltimore, Md.)62 (3) : 702-14
Interferon-inducible cholesterol-25-hydroxylase restricts hepatitis C virus replication through blockage of membranous web formation
Anggakusuma, Romero-Brey I, Berger C, Colpitts C, Boldanova T, Engelmann M, Todt D, Perin P, Behrendt P, Vondran F, Xu S, Goffinet C, Schang L, Heim M, Bartenschlager R, Pietschmann T, Steinmann E
2015The Journal of General Virology96 (9) : 2636-2642
Assessment of cross-species transmission of hepatitis C virus-related non-primate hepacivirus in a population of humans at high risk of exposure
Pfaender S, Walter S, Todt D, Behrendt P, Doerrbecker J, Wölk B, Engelmann M, Gravemann U, Seltsam A, Steinmann J, Burbelo P, Klawonn F, Feige K, Pietschmann T, Cavalleri J, Steinmann E
2015Genes and Immunity16 (6) : 414-21
Transcriptome analysis reveals a classical interferon signature induced by IFNλ4 in human primary cells
Lauber C, Vieyres G, Terczyńska-Dyla E, Anggakusuma, Dijkman R, Gad H, Akhtar H, Geffers R, Vondran F, Thiel V, Kaderali L, Pietschmann T, Hartmann R
2015Journal of Hepatology63 (4) : 813-21
Soraphen A: A broad-spectrum antiviral natural product with potent anti-hepatitis C virus activity
Koutsoudakis G, Romero-Brey I, Berger C, Pérez-Vilaró G, Monteiro Perin P, Vondran F, Kalesse M, Harmrolfs K, Müller R, Martinez J, Pietschmann T, Bartenschlager R, Brönstrup M, Meyerhans A, Díez J